Evaluation of tumor-infiltrating lymphocytes in breast cancer; proposal of a simpler method
- PMID: 26347098
- DOI: 10.1093/annonc/mdv363
Evaluation of tumor-infiltrating lymphocytes in breast cancer; proposal of a simpler method
Comment on
-
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.Ann Oncol. 2015 Feb;26(2):259-71. doi: 10.1093/annonc/mdu450. Epub 2014 Sep 11. Ann Oncol. 2015. PMID: 25214542 Free PMC article.
Similar articles
-
Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.Breast Cancer. 2019 Sep;26(5):573-580. doi: 10.1007/s12282-019-00958-3. Epub 2019 Mar 13. Breast Cancer. 2019. PMID: 30868399
-
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.Tumour Biol. 2017 Apr;39(4):1010428317695023. doi: 10.1177/1010428317695023. Tumour Biol. 2017. PMID: 28378631 Review.
-
Diagnostic and therapeutic implications of tumor-infiltrating lymphocytes in breast cancer.J Clin Oncol. 2013 Mar 1;31(7):836-7. doi: 10.1200/JCO.2012.47.1698. Epub 2013 Jan 22. J Clin Oncol. 2013. PMID: 23341523 No abstract available.
-
Tumor infiltrating lymphocytes in early breast cancer.Breast. 2018 Feb;37:207-214. doi: 10.1016/j.breast.2017.03.010. Epub 2017 Mar 28. Breast. 2018. PMID: 28363679 Review.
-
[Highly expressed CD147 on CD4⁺ tumor infiltrating lymphocytes promotes the progress of breast cancer].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jul;31(7):961-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015. PMID: 26146069 Chinese.
Cited by
-
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.Breast Cancer Res Treat. 2016 Jul;158(1):1-9. doi: 10.1007/s10549-016-3848-2. Epub 2016 Jun 3. Breast Cancer Res Treat. 2016. PMID: 27260189 Free PMC article.
-
Low neutrophil-lymphocyte ratio correlates with extended survival in patients with metastatic breast cancer who achieved clinically complete response following multidisciplinary therapy: A retrospective study.Oncol Lett. 2018 May;15(5):6681-6687. doi: 10.3892/ol.2018.8145. Epub 2018 Mar 1. Oncol Lett. 2018. PMID: 29725410 Free PMC article.
-
Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immune Microenvironment.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218227. doi: 10.1177/15330338231218227. Technol Cancer Res Treat. 2023. PMID: 38111330 Free PMC article. Review.
-
The density of tumor-infiltrating lymphocytes and prognosis in resectable hepatocellular carcinoma: a two-phase study.Aging (Albany NY). 2021 Mar 19;13(7):9665-9678. doi: 10.18632/aging.202710. Epub 2021 Mar 19. Aging (Albany NY). 2021. PMID: 33744864 Free PMC article.
-
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.Nat Commun. 2024 May 7;15(1):3837. doi: 10.1038/s41467-024-47932-y. Nat Commun. 2024. PMID: 38714665 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical